HK Stock MarketDetailed Quotes

02181 MABPHARM-B

Watchlist
  • 0.415
  • 0.0000.00%
Pre-Opening Auction Apr 30 09:06 CST
1.71BMarket Cap-7410P/E (TTM)

MABPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
55.87%87.16M
52.60%44.02M
-32.53%55.92M
-64.49%28.85M
--82.88M
--81.25M
----
----
----
----
Operating income
55.87%87.16M
52.60%44.02M
-32.53%55.92M
-64.49%28.85M
82.88M
81.25M
Cost of sales
22.45%-11.92M
43.93%-6.2M
8.36%-15.38M
34.08%-11.05M
---16.78M
---16.77M
----
----
----
----
Operating expenses
22.45%-11.92M
43.93%-6.2M
8.36%-15.38M
34.08%-11.05M
-16.78M
-16.77M
Gross profit
85.58%75.24M
112.57%37.82M
-38.67%40.54M
-72.40%17.79M
66.11M
64.48M
Selling expenses
-73.41%-48.93M
-77.18%-27.05M
-199.41%-28.21M
---15.26M
---9.42M
----
----
----
----
----
Administrative expenses
-15.57%-104.66M
1.42%-47.15M
0.08%-90.56M
-9.32%-47.83M
-37.75%-90.63M
-42.33%-43.76M
-4.52%-65.8M
-10.25%-30.74M
-49.43%-62.95M
---27.88M
Research and development expenses
16.70%-123.21M
23.67%-59.53M
43.88%-147.91M
52.29%-77.99M
-118.88%-263.57M
-168.72%-163.46M
10.26%-120.42M
-3.62%-60.83M
-50.80%-134.19M
---58.7M
Impairment and provision
-261.86%-427K
---639K
---118K
----
----
----
----
----
----
----
-Other impairment is provision
-261.86%-427K
---639K
---118K
----
----
----
----
----
----
----
Special items of operating profit
-90.25%2.21M
-89.13%1.04M
176.49%22.62M
925.84%9.59M
48.13%8.18M
-102.90%-1.16M
-81.49%5.52M
1,564.10%40.01M
226.95%29.83M
--2.4M
Operating profit
1.89%-199.78M
16.01%-95.5M
29.62%-203.63M
20.98%-113.71M
-60.13%-289.34M
-179.06%-143.89M
-8.00%-180.69M
38.75%-51.56M
-37.15%-167.31M
-84.18M
Financing cost
-33.25%-9.58M
-44.91%-4.5M
-199.13%-7.19M
-144.99%-3.1M
39.04%-2.4M
51.71%-1.27M
48.77%-3.94M
33.95%-2.62M
-71.73%-7.7M
---3.97M
Special items of earning before tax
----
----
----
----
----
----
----
----
-5.36%-27.53M
---27.53M
Earning before tax
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-32.72%-202.53M
-115.68M
After-tax profit from continuing operations
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-35.24%-202.53M
-115.68M
Earning after tax
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-35.24%-202.53M
-115.68M
Profit attributable to shareholders
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-62.17%-202.53M
-115.68M
Basic earnings per share
0.00%-0.05
33.33%-0.02
28.57%-0.05
25.00%-0.03
-75.00%-0.07
-300.00%-0.04
20.00%-0.04
66.67%-0.01
16.67%-0.05
-0.03
Diluted earnings per share
0.00%-0.05
33.33%-0.02
28.57%-0.05
25.00%-0.03
-75.00%-0.07
-300.00%-0.04
20.00%-0.04
66.67%-0.01
16.67%-0.05
-0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 55.87%87.16M52.60%44.02M-32.53%55.92M-64.49%28.85M--82.88M--81.25M----------------
Operating income 55.87%87.16M52.60%44.02M-32.53%55.92M-64.49%28.85M82.88M81.25M
Cost of sales 22.45%-11.92M43.93%-6.2M8.36%-15.38M34.08%-11.05M---16.78M---16.77M----------------
Operating expenses 22.45%-11.92M43.93%-6.2M8.36%-15.38M34.08%-11.05M-16.78M-16.77M
Gross profit 85.58%75.24M112.57%37.82M-38.67%40.54M-72.40%17.79M66.11M64.48M
Selling expenses -73.41%-48.93M-77.18%-27.05M-199.41%-28.21M---15.26M---9.42M--------------------
Administrative expenses -15.57%-104.66M1.42%-47.15M0.08%-90.56M-9.32%-47.83M-37.75%-90.63M-42.33%-43.76M-4.52%-65.8M-10.25%-30.74M-49.43%-62.95M---27.88M
Research and development expenses 16.70%-123.21M23.67%-59.53M43.88%-147.91M52.29%-77.99M-118.88%-263.57M-168.72%-163.46M10.26%-120.42M-3.62%-60.83M-50.80%-134.19M---58.7M
Impairment and provision -261.86%-427K---639K---118K----------------------------
-Other impairment is provision -261.86%-427K---639K---118K----------------------------
Special items of operating profit -90.25%2.21M-89.13%1.04M176.49%22.62M925.84%9.59M48.13%8.18M-102.90%-1.16M-81.49%5.52M1,564.10%40.01M226.95%29.83M--2.4M
Operating profit 1.89%-199.78M16.01%-95.5M29.62%-203.63M20.98%-113.71M-60.13%-289.34M-179.06%-143.89M-8.00%-180.69M38.75%-51.56M-37.15%-167.31M-84.18M
Financing cost -33.25%-9.58M-44.91%-4.5M-199.13%-7.19M-144.99%-3.1M39.04%-2.4M51.71%-1.27M48.77%-3.94M33.95%-2.62M-71.73%-7.7M---3.97M
Special items of earning before tax ---------------------------------5.36%-27.53M---27.53M
Earning before tax 0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-32.72%-202.53M-115.68M
After-tax profit from continuing operations 0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-35.24%-202.53M-115.68M
Earning after tax 0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-35.24%-202.53M-115.68M
Profit attributable to shareholders 0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-62.17%-202.53M-115.68M
Basic earnings per share 0.00%-0.0533.33%-0.0228.57%-0.0525.00%-0.03-75.00%-0.07-300.00%-0.0420.00%-0.0466.67%-0.0116.67%-0.05-0.03
Diluted earnings per share 0.00%-0.0533.33%-0.0228.57%-0.0525.00%-0.03-75.00%-0.07-300.00%-0.0420.00%-0.0466.67%-0.0116.67%-0.05-0.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg